Respiratory Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/respiratory/ The leading site for news and procurement in the pharmaceutical industry Fri, 12 Apr 2024 09:06:49 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Respiratory Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/respiratory/ 32 32 FDA approves AstraZeneca’s FASENRA for asthma in children https://www.pharmaceutical-technology.com/news/fda-astrazeneca-fasenra/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/astrazeneca-2.jpg Fri, 12 Apr 2024 08:11:40 +0000 https://www.pharmaceutical-technology.com/news/fda-astrazeneca-fasenra/ GSK expands Asia-Pacific reach for Trelegy Ellipta with Singapore approval https://www.pharmaceutical-technology.com/news/gsk-expands-asia-pacific-reach-for-trelegy-ellipta-with-singapore-approval/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2262780591.jpg Fri, 05 Apr 2024 13:59:39 +0000 https://www.pharmaceutical-technology.com/news/gsk-expands-asia-pacific-reach-for-trelegy-ellipta-with-singapore-approval/ Nocion secures Series B funds to develop cough treatment https://www.pharmaceutical-technology.com/news/nocion-funds-cough-treatment/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/Nocion.jpg Tue, 05 Mar 2024 08:23:12 +0000 https://www.pharmaceutical-technology.com/news/nocion-funds-cough-treatment/ FDA to decide on Sanofi/Regeneron’s Dupixent for COPD in June https://www.pharmaceutical-technology.com/news/fda-to-decide-on-sanofi-regenerons-dupixent-for-copd-in-june/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_1660646002.jpg Fri, 23 Feb 2024 15:12:27 +0000 https://www.pharmaceutical-technology.com/news/fda-to-decide-on-sanofi-regenerons-dupixent-for-copd-in-june/ Regeneron and Sanofi’s Dupixent bags fifth drug label in Japan https://www.pharmaceutical-technology.com/news/regeneron-and-sanofis-dupixent-bags-fifth-drug-label-in-japan/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_2151657455.jpg Fri, 16 Feb 2024 15:58:54 +0000 https://www.pharmaceutical-technology.com/news/regeneron-and-sanofis-dupixent-bags-fifth-drug-label-in-japan/ GSK concludes Aiolos Bio acquisition for $1.4bn https://www.pharmaceutical-technology.com/news/gsk-aiolos-bio-acquisition/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/gsk-2.jpg Fri, 16 Feb 2024 08:12:33 +0000 https://www.pharmaceutical-technology.com/news/gsk-aiolos-bio-acquisition/ Vicore licenses idiopathic pulmonary fibrosis therapy to Nippon in Japan https://www.pharmaceutical-technology.com/news/vicore-licenses-idiopathic-pulmonary-fibrosis-therapy-to-nippon-in-japan/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_679194760-scaled.jpg Fri, 09 Feb 2024 15:44:25 +0000 https://www.pharmaceutical-technology.com/news/vicore-licenses-idiopathic-pulmonary-fibrosis-therapy-to-nippon-in-japan/ Inhalation Sciences and Actarmo enter respiratory drugs collaboration https://www.pharmaceutical-technology.com/news/inhalation-sciences-actarmo-deal/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/Inhalation-Sciences-.jpg Tue, 23 Jan 2024 10:04:47 +0000 https://www.pharmaceutical-technology.com/news/inhalation-sciences-actarmo-deal/ GSK’s Nucala for severe eosinophilic asthma gains approval in China https://www.pharmaceutical-technology.com/news/gsks-nucala-china/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_1682639740.jpg Thu, 11 Jan 2024 08:43:11 +0000 https://www.pharmaceutical-technology.com/news/gsks-nucala-china/ GSK acquires Aiolos Bio for $1.4bn to boost respiratory portfolio https://www.pharmaceutical-technology.com/news/gsk-acquires-aiolos-bio-for-1-4bn-to-boost-respiratory-portfolio/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_1123492958.jpg Wed, 10 Jan 2024 11:32:13 +0000 https://www.pharmaceutical-technology.com/news/gsk-acquires-aiolos-bio-for-1-4bn-to-boost-respiratory-portfolio/